For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research ...
Shenglin Mei of Virginia Tech's Fralin Biomedical Research Institute was part of a multi-institutional team including researchers from Harvard Medical School, Massachusetts General Hospital, the ...
A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...
On World Cancer Day 2026, oncologists spoke about the early signs of prostate cancer, which are often mistaken for ...
Of all the health conditions facing men as they get older, there is no doubt that prostate cancer is the most widely ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
In recognition of National Cancer Prevention Month, ProCure Proton Therapy Center is urging men to prioritize prostate-specific antigen (PSA) screenings—often the simplest first step in detecting ...
After skin cancer, prostate cancer is the most common type of cancer affecting men. It is a potentially aggressive and life-threatening disease that begins when cancerous cells form in the prostate—a ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results